| Name | Cevidoplenib dimesylate |
|---|---|
| Synonyms |
Methanone, cyclopropyl[5-[[4-[4-[[(4S)-4-hydroxy-2-isoxazolidinyl]methyl]-3-methyl-1H-pyrazol-1-yl]-2-pyrimidinyl]amino]-1-methyl-1H-indol-3-yl]-, methanesulfonate (1:2)
(S)-Cyclopropyl(5-((4-(4-((4-hydroxyisoxazolidin-2-yl)methyl)-3-methyl-1H-pyrazol-1-yl)pyrimidin-2-yl)amino)-1-methyl-1H-indol-3-yl)methanone dimethanesulfonate Cevidoplenib dimesylate,B-cell,anti-inflammatory,Syk,immunomodulating,neutrophils,macrophages,Inhibitor,Spleen tyrosine kinase,inhibit Cevidoplenib dimesylate(SKI-O-703 dimesylate) Cevidoplenib dimesylate, 10 mM in DMSO |
| Description | Cevidoplenib is an orally available inhibitor of spleen tyrosine kinase (Syk), with potential anti-inflammatory and immunomodulating activities[1][2]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C27H35N7O9S2 |
|---|---|
| Molecular Weight | 665.74 |